Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bhag Karamchandani who wrote (4508)	6/17/1998 12:55:00 PM
From: tommysdad	Read Replies (2) of 6136

<<Can some one offer an empirical definition of " stabilized" ?>> They didn't get worse. I'm not being glib -- that's really what that means. SF asks what this data means -- good or bad. Essentially, a PI trial is a safety trial and any efficacy on the order of what they are reporting is not statistically significant and translation to PII/III is fairly random. So, if you're a glass-half-full kind of guy, it's "good", if you're a glass-half-empty kind of guy, it's "neutral". All this data means is that they can go forward to PII, which we already knew they had done. In a rational market, this news would have little impact.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next